Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Outcomes of a routine invasive strategy in elderly patients with non-ST-segment elevation myocardial infarction from 2005 to 2014: results from the PL-ACS registry.

Piątek Ł, Wilczek K, Janion-Sadowska A, Gierlotka M, Gąsior M, Sadowski M.

Coron Artery Dis. 2019 Feb 4. doi: 10.1097/MCA.0000000000000708. [Epub ahead of print]

PMID:
30724817
2.

Annual Trends in Total Ischemic Time and One-Year Fatalities: The Paradox of STEMI Network Performance Assessment.

Kawecki D, Morawiec B, Gąsior M, Wilczek K, Nowalany-Kozielska E, Gierlotka M.

J Clin Med. 2019 Jan 11;8(1). pii: E78. doi: 10.3390/jcm8010078.

3.

Technical solution during challenging implantation of CoreValve Evolut R 34 prosthesis in patient with bicuspid aortic valve with large annulus.

Chodór P, Wilczek K, Chodór-Rozwadowska K, Przybylski R, Zembala M, Kalarus Z.

Postepy Kardiol Interwencyjnej. 2018;14(4):433-434. doi: 10.5114/aic.2018.79875. Epub 2018 Dec 11. No abstract available.

4.

Gender-related differences in men and women with ST-segment elevation myocardial infarction and incomplete infarct-related artery flow restoration: a multicenter national registry.

Zachura M, Wilczek K, Kurzawski J, Gierlotka M, Gąsior M, Sadowski M.

Postepy Kardiol Interwencyjnej. 2018;14(4):356-362. doi: 10.5114/aic.2018.79865. Epub 2018 Dec 11.

5.

Impact of routine invasive strategy on outcomes in patients with non-ST segment elevation myocardial infarction during 2005-2014: A report from the Polish Registry of Acute Coronary Syndromes (PL-ACS).

Piątek Ł, Wilczek K, Kurzawski J, Gierlotka M, Gąsior M, Poloński L, Sadowski M.

Cardiol J. 2018 Nov 8. doi: 10.5603/CJ.a2018.0136. [Epub ahead of print]

6.

A designer bow-tie combination therapeutic platform: An approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation.

Pathak RK, Basu U, Ahmad A, Sarkar S, Kumar A, Surnar B, Ansari S, Wilczek K, Ivan ME, Marples B, Kolishetti N, Dhar S.

Biomaterials. 2018 Dec;187:117-129. doi: 10.1016/j.biomaterials.2018.08.062. Epub 2018 Sep 5.

PMID:
30336364
7.

Transcatheter aortic valve-in-valve implantation in failed stentless bioprostheses.

Huczek Z, Grodecki K, Scisło P, Wilczek K, Jagielak D, Fil W, Kubler P, Olszówka P, Dąbrowski M, Frank M, Grygier M, Kidawa M, Wilimski R, Żelazowska K, Witkowski A, Kochman J, Zembala M, Opolski G, Dvir D, Wojakowski W.

J Interv Cardiol. 2018 Dec;31(6):861-869. doi: 10.1111/joic.12540. Epub 2018 Jul 15.

PMID:
30009390
8.

Platelet-to-lymphocyte ratio predicts contrast-induced acute kidney injury in diabetic patients with ST-elevation myocardial infarction.

Hudzik B, Szkodziński J, Korzonek-Szlacheta I, Wilczek K, Gierlotka M, Lekston A, Zubelewicz-Szkodzińska B, Gąsior M.

Biomark Med. 2017 Oct;11(10):847-856. doi: 10.2217/bmm-2017-0120. Epub 2017 Oct 4.

PMID:
28976786
9.

Impact of CoreValve size selection based on multi-slice computed tomography on paravalvular leak after transcatheter aortic valve implantation.

Chodór P, Wilczek K, Przybylski R, Głowacki J, Kukulski T, Streb W, Niklewski T, Honisz G, Trzeciak P, Podolecki T, Włoch Ł, Zembala M, Kalarus Z.

Cardiol J. 2017;24(5):467-476. doi: 10.5603/CJ.a2017.0014. Epub 2017 Feb 2.

10.

POL-TAVI - Polish Registry of Transcatheter Aortic Valve Implantation - simple tool, great value, rationale and design.

Zembala-John J, Wilczek K, Tobota Z, Chodór P, Cieśla D, Jaźwiec T, Banasiak W, Stępińska J, Kalarus Z, Opolski G, Zembala M.

Kardiochir Torakochirurgia Pol. 2016 Dec;13(4):309-315. doi: 10.5114/kitp.2016.64870. Epub 2016 Dec 30.

11.

Assessment of cardiovascular function following transcatheter aortic valve implantation based on six-minute walk test.

Chodór P, Wilczek K, Zielińska T, Przybylski R, Głowacki J, Włoch Ł, Zembala M, Kalarus Z.

Cardiol J. 2017;24(2):167-175. doi: 10.5603/CJ.a2016.0086. Epub 2016 Oct 7.

12.

Conduction disturbances after transcatheter aortic valve implantation procedures - predictors and management.

Wilczek K, Reguła R, Bujak K, Chodór P, Długaszek M, Gąsior M.

Postepy Kardiol Interwencyjnej. 2016;12(3):203-11. doi: 10.5114/aic.2016.61640. Epub 2016 Aug 19. Review.

13.

Our findings differ.

Hudzik B, Wilczek K, Gasior M.

CMAJ. 2015 Oct 20;187(15):1162. doi: 10.1503/cmaj.1150068. No abstract available.

14.

Risk factors for paravalvular leak after transcatheter aortic valve implantation.

Wilczek K, Bujak K, Reguła R, Chodór P, Osadnik T.

Kardiochir Torakochirurgia Pol. 2015 Jun;12(2):89-94. doi: 10.5114/kitp.2015.52848. Epub 2015 Jun 30.

15.

The role of balloon aortic valvuloplasty in the era of transcatheter aortic valve implantation.

Wacławski J, Wilczek K, Pres D, Krajewski A, Poloński L, Zembala M, Gąsior M.

Kardiochir Torakochirurgia Pol. 2015 Mar;12(1):8-13. doi: 10.5114/kitp.2015.50561. Epub 2015 Mar 31.

16.

Large-scale production of lentiviral vector in a closed system hollow fiber bioreactor.

Sheu J, Beltzer J, Fury B, Wilczek K, Tobin S, Falconer D, Nolta J, Bauer G.

Mol Ther Methods Clin Dev. 2015 Jun 17;2:15020. doi: 10.1038/mtm.2015.20. eCollection 2015.

17.

Heyde syndrome: gastrointestinal bleeding and aortic stenosis.

Hudzik B, Wilczek K, Gasior M.

CMAJ. 2016 Feb 2;188(2):135-8. doi: 10.1503/cmaj.150194. Epub 2015 Jun 29. No abstract available.

18.

Transfemoral transcatheter aortic valve implantation in a patient with a severe aortic stenosis and cardiogenic shock requiring intra-aortic balloon pump support.

Chodór P, Wilczek K, Przybylski R, Świątkowski A, Głowacki J, Kalarus Z, Zembala M.

Postepy Kardiol Interwencyjnej. 2015;11(1):55-7. doi: 10.5114/pwki.2015.49187. Epub 2015 Mar 6.

19.

Comparison of one- and 12-month outcomes of transcatheter aortic valve replacement in patients with severely stenotic bicuspid versus tricuspid aortic valves (results from a multicenter registry).

Kochman J, Huczek Z, Scisło P, Dabrowski M, Chmielak Z, Szymański P, Witkowski A, Parma R, Ochala A, Chodór P, Wilczek K, Reczuch KW, Kubler P, Rymuza B, Kołtowski L, Scibisz A, Wilimski R, Grube E, Opolski G.

Am J Cardiol. 2014 Sep 1;114(5):757-62. doi: 10.1016/j.amjcard.2014.05.063. Epub 2014 Jun 19.

PMID:
25037674
20.

Prognostic significance of mean platelet volume in diabetic patients with ST-elevation myocardial infarction.

Lekston A, Hudzik B, Hawranek M, Szkodzinski J, Gorol J, Wilczek K, Gasior M, Polonski L.

J Diabetes Complications. 2014 Sep-Oct;28(5):652-7. doi: 10.1016/j.jdiacomp.2014.05.002. Epub 2014 May 16.

PMID:
24942286
21.

Symetis Acurate Transapical Aortic Valve: the initial experience with a second generation of transcatheter aortic valve replacement device.

Zembala MO, Piegza J, Wacławski J, Hawranek M, Hilker M, Niklewski T, Głowacki J, Parys M, Nadziakiewicz P, Chodór P, Wilczek K, Przybylski R, Gąsior M, Zembala M.

Kardiol Pol. 2014;72(2):187-93. doi: 10.5603/KP.2014.0029.

PMID:
24604504
22.

Evaluation of the usefulness of coronary catheters and 4 Fr insertion sets for transradial access coronarography in comparison with catheters and 5 Fr sets.

Chodór P, Morawski S, Sulik-Gajda S, Ramus N, Kowalczyk J, Honisz G, Wilczek K, Sredniawa B, Kalarus Z.

Postepy Kardiol Interwencyjnej. 2013;9(4):332-6. doi: 10.5114/pwki.2013.38860. Epub 2013 Nov 18.

23.

Red cell distribution width is associated with long-term prognosis in patients with stable coronary artery disease.

Osadnik T, Strzelczyk J, Hawranek M, Lekston A, Wasilewski J, Kurek A, Gutowski AR, Wilczek K, Dyrbuś K, Gierlotka M, Wiczkowski A, Gąsior M, Szafranek A, Poloński L.

BMC Cardiovasc Disord. 2013 Dec 10;13:113. doi: 10.1186/1471-2261-13-113.

24.

Distortion of the CoreValve during transcatheter aortic valve-in-valve implantation due to valve dislocation.

Souteyrand G, Wilczek K, Innorta A, Camilleri L, Chodor P, Lusson JR, Motreff P, Laborde JC, Chabrot P, Durel N.

Cardiovasc Revasc Med. 2013 Sep-Oct;14(5):294-8. doi: 10.1016/j.carrev.2013.05.004. Epub 2013 Aug 9.

PMID:
23933060
25.

Outcomes of invasive treatment in very elderly Polish patients with non-ST-segment-elevation myocardial infarction from 2003-2009 (from the PL-ACS registry).

Gierlotka M, Gąsior M, Tajstra M, Hawranek M, Osadnik T, Wilczek K, Kalarus Z, Lekston A, Zembala M, Poloński L.

Cardiol J. 2013;20(1):34-43. doi: 10.5603/CJ.2013.0007.

26.

Calcific aortic valve damage as a risk factor for cardiovascular events.

Wasilewski J, Mirota K, Wilczek K, Głowacki J, Poloński L.

Pol J Radiol. 2012 Oct;77(4):30-4.

27.

Impact of chronic total occlusion artery on 12-month mortality in patients with non-ST-segment elevation myocardial infarction treated by percutaneous coronary intervention (from the PL-ACS Registry).

Gierlotka M, Tajstra M, Gąsior M, Hawranek M, Osadnik T, Wilczek K, Olszowski D, Dyrbuś K, Poloński L.

Int J Cardiol. 2013 Sep 20;168(1):250-4. doi: 10.1016/j.ijcard.2012.09.086. Epub 2012 Oct 8.

PMID:
23058348
28.

Role of miRNAs in neuronal differentiation from human embryonic stem cell-derived neural stem cells.

Liu J, Githinji J, Mclaughlin B, Wilczek K, Nolta J.

Stem Cell Rev. 2012 Dec;8(4):1129-37. doi: 10.1007/s12015-012-9411-6.

29.

Temporal trends in the treatment and outcomes of patients With non-ST-segment elevation myocardial infarction in Poland from 2004-2010 (from the Polish Registry of Acute Coronary Syndromes).

Gierlotka M, Gąsior M, Wilczek K, Wasilewski J, Hawranek M, Tajstra M, Osadnik T, Banasiak W, Poloński L.

Am J Cardiol. 2012 Mar 15;109(6):779-86. doi: 10.1016/j.amjcard.2011.10.041. Epub 2011 Dec 19.

PMID:
22189010
30.

What has changed in the treatment of ST-segment elevation myocardial infarction in Poland in 2003-2009? Data from the Polish Registry of Acute Coronary Syndromes (PL-ACS).

Poloński L, Gąsior M, Gierlotka M, Wilczek K, Kalarus Z, Dubiel J, Rużyłło W, Banasiak W, Opolski G, Zembala M.

Kardiol Pol. 2011;69(11):1109-18.

31.

Mortality of patients with ST-segment elevation myocardial infarction and cardiogenic shock treated by PCI is correlated to the infarct-related artery--results from the PL-ACS Registry.

Trzeciak P, Gierlotka M, Gąsior M, Lekston A, Wilczek K, Słonka G, Kalarus Z, Zembala M, Hudzik B, Poloński L.

Int J Cardiol. 2013 Jun 5;166(1):193-7. doi: 10.1016/j.ijcard.2011.10.100. Epub 2011 Nov 15.

PMID:
22088222
32.

Serum interleukin-6 concentration reflects the extent of asymptomatic left ventricular dysfunction and predicts progression to heart failure in patients with stable coronary artery disease.

Hudzik B, Szkodzinski J, Romanowski W, Danikiewicz A, Wilczek K, Lekston A, Polonski L, Zubelewicz-Szkodzinska B.

Cytokine. 2011 Jun;54(3):266-71. doi: 10.1016/j.cyto.2011.02.012. Epub 2011 Mar 5.

PMID:
21382729
33.

Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]).

Gierlotka M, Gasior M, Wilczek K, Hawranek M, Szkodzinski J, Paczek P, Lekston A, Kalarus Z, Zembala M, Polonski L.

Am J Cardiol. 2011 Feb 15;107(4):501-8. doi: 10.1016/j.amjcard.2010.10.008. Epub 2010 Dec 31.

PMID:
21195380
34.

Management of diastolic heart failure.

Kazik A, Wilczek K, Poloński L.

Cardiol J. 2010;17(6):558-65. Review.

35.

Comparison of invasive and non-invasive treatment strategies in older patients with acute myocardial infarction complicated by cardiogenic shock (from the Polish Registry of Acute Coronary Syndromes - PL-ACS).

Gasior M, Slonka G, Wilczek K, Gierlotka M, Ruzyllo W, Zembala M, Osadnik T, Dubiel J, Zdrojewski T, Kalarus Z, Polonski L.

Am J Cardiol. 2011 Jan;107(1):30-6. doi: 10.1016/j.amjcard.2010.08.039.

PMID:
21146682
37.

Effect of omeprazole on the concentration of interleukin-6 and transforming growth factor-β1 in patients receiving dual antiplatelet therapy after percutaneous coronary intervention.

Hudzik B, Szkodzinski J, Danikiewicz A, Wilczek K, Romanowski W, Lekston A, Polonski L, Zubelewicz-Szkodzinska B.

Eur Cytokine Netw. 2010 Dec;21(4):257-63. doi: 10.1684/ecn.2010.0213. Epub 2010 Nov 18.

38.

Immediate and 6-month outcomes of transapical and transfemoral Edwards-Sapien prosthesis implantation in patients with aortic stenosis.

Chodór P, Wilczek K, Przybylski R, Krasoń M, Głowacki J, Niklewski T, Podolecki T, Kalarus Z, Poloński L, Zembala M.

Kardiol Pol. 2010 Oct;68(10):1124-31.

39.

["Vale-in-valve" - first Polish experience in transcatheter treatment of patient with high-risk of redo surgery for degenerative disease of aortic bioprosthesis, using tranaxillary access].

Wilczek K, Chodór P, Walas R, Krasoń M, Przybylski R, Niklewski T, Głowacki J, Nadziakiewicz P, Kowalik V, Motyka M, Laborde JC, Zembala M.

Kardiol Pol. 2010 Aug;68(8):980-4. Polish. No abstract available.

40.

A comparison of ST elevation versus non-ST elevation myocardial infarction outcomes in a large registry database: are non-ST myocardial infarctions associated with worse long-term prognoses?

Polonski L, Gasior M, Gierlotka M, Osadnik T, Kalarus Z, Trusz-Gluza M, Zembala M, Wilczek K, Lekston A, Zdrojewski T, Tendera M; PL-ACS Registry Pilot Group.

Int J Cardiol. 2011 Oct 6;152(1):70-7. doi: 10.1016/j.ijcard.2010.07.008. Epub 2010 Aug 3.

PMID:
20684999
41.
42.

Serum concentration of insulin-like growth factor-I, but not tumor necrosis factor-alpha, measured twelve months after stenting of the infarct-related artery, is associated with in-stent restenosis.

Szkodzinski J, Hudzik B, Romanowski W, Wilczek K, Danikiewicz A, Gasior M, Polonski L, Zubelewicz-Szkodzinska B.

J Biol Regul Homeost Agents. 2010 Apr-Jun;24(2):149-56.

PMID:
20487628
43.

Progression of coronary artery atherosclerosis after acute myocardial infarction: an angiographic study.

Hawranek M, Gasior M, Gierlotka M, Wilczek K, Lekston A, Szygula-Jurkiewicz B, Spatuszko A, Polonski L.

J Invasive Cardiol. 2010 May;22(5):209-15.

44.

Comparison of long-term results of drug-eluting stent and bare metal stent implantation in heart transplant recipients with coronary artery disease.

Lekston A, Zakliczyński M, Gasior M, Osuch M, Wilczek K, Kalarus Z, Osadnik T, Poloński L, Zembala M.

Kardiol Pol. 2010 Feb;68(2):131-4.

45.

[Percutaneous transfemoral aortic CoreValve(R) implantations in high risk patients--another Polish good experience].

Wilczek K, Chodór P, Laborde JC, Przybylski R, Krasoń M, Niklewski T, Głowacki J, Nadziakiewicz P, Kusa J, Kalarus Z, Poloński L, Zembala M.

Kardiol Pol. 2009 Oct;67(10):1162-5. Polish. No abstract available.

46.

Comparison of early and late efficacy of percutaneous transluminal renal angioplasty with or without subsequent brachytherapy: the effect on blood pressure in patients with renovascular hypertension.

Lekston A, Chudek J, Wilczek K, Gasior M, Wiecek A, Kokot F, Fijałkowski M, Gierlotka M, Szyguła-Jurkiewicz B, Wojnicz R, Białas B, Osuch M, Maciejewski B, Poloński L.

Cardiol J. 2009;16(6):514-20.

47.

No predictive value of serum interleukin-6 and transforming growth factor-beta1 in identifying patients with a first restenosis, recurrent restenosis or a history of restenosis.

Hudzik B, Szkodzinski J, Romanowski W, Wilczek K, Wojnar R, Lekston A, Polonski L, Zubelewicz-Szkodzinska B.

Eur Cytokine Netw. 2009 Sep;20(3):135-9. doi: 10.1684/ecn.2009.0160.

48.

[POL-TAVI First--Polish report on transcatheter aortic valve implantation (TAVI) of Edwards-Sapien prosthesis in the first 19 high risk patients with severe aortic stenosis and comorbidities].

Zembala M, Wilczek K, Przybylski R, Chodór P, Nadziakiewicz P, Krasoń M, Sadowski J, Dudek D, Kapelak B, Forysz D, Witkowski A, Demkow M, Chmielak Z, Kuśmierski K, Juraszyński Z, Bochenek A, Cisowski M, Trusz-Gluza M, Buszman P, Woś S, Kalarus Z, Poloński L, Gasior M, Opolski G, Ruzyłło W.

Kardiol Pol. 2009 Aug;67(8):936-40. Polish.

49.

The role of interleukin-6 and transforming growth factor-beta1 in predicting restenosis within stented infarct-related artery.

Szkodzinski J, Blazelonis A, Wilczek K, Hudzik B, Romanowski W, Gasior M, Wojnar R, Lekston A, Polonski L, Zubelewicz-Szkodzinska B.

Int J Immunopathol Pharmacol. 2009 Apr-Jun;22(2):493-500.

PMID:
19505401
50.

Effects of short- and long-term efficacy of percutaneous transluminal renal angioplasty with or without intravascular brachytherapy on regression of left ventricular hypertrophy in patients with renovascular hypertension.

Lekston A, Niklewski T, Gasior M, Chudek J, Wilczek K, Wiecek A, Kokot F, Fijałkowski M, Gierlotka M, Osuch M, Maciejewski B, Poloński L.

Pol Arch Med Wewn. 2009 Apr;119(4):211-8.

Supplemental Content

Loading ...
Support Center